Richard Diiorio - InfuSystems Holdings President CEO, Director

INFU Stock  USD 9.33  0.09  0.97%   

CEO

Mr. Richard A. Diiorio is President, Chief Executive Officer, Director of the Company. Mr. DiIorio brings a strong track record of accomplishment with more than 17 years of medical sales experience, extensive expertise in product launch, and industry knowledge focused on driving growth in the oncology market. Mr. DiIorio has served as a member of the Company Office of the President since May 2017 and as General Manager of Oncology since December 2016. Mr. DiIorio served as InfuSystem Executive Vice President of Oncology Sales from July 2014 to November 2016 and Regional Vice President and Vice President Strategic Development from August 2010 to July 2014 since 2017.
Age 49
Tenure 7 years
Phone248 291 1210
Webhttps://www.infusystem.com
DiIorio joined InfuSystem inJanuary 2004 and served as Territory Manager until July 2010. During Mr. DiIorio 13year tenure with InfuSystem, he has received numerous awards and honors. Prior to joining the Company, Mr. DiIorio held various sales and sales leadership roles at Stryker Medical, Novartis Pharmaceuticals, and Thermo Scientific. He earned a BS degree in Biology from Boston College.

InfuSystems Holdings Management Efficiency

The company has return on total asset (ROA) of 0.0333 % which means that it generated a profit of $0.0333 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0277 %, meaning that it created $0.0277 on every $100 dollars invested by stockholders. InfuSystems Holdings' management efficiency ratios could be used to measure how well InfuSystems Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
InfuSystems Holdings currently holds 36.37 M in liabilities with Debt to Equity (D/E) ratio of 0.82, which is about average as compared to similar companies. InfuSystems Holdings has a current ratio of 1.56, which is within standard range for the sector. Note, when we think about InfuSystems Holdings' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 7 records

CEO Age

Brian BalbirnieIssuer Direct Corp
53
Jan HaverhalsMilestone Scientific
62
Sanjiv RazdanThe Joint Corp
N/A
Kathleen SkarvanElectromed
68
Leonard OsserMilestone Scientific
77
Peter HoltThe Joint Corp
65
David BruceIRIDEX
65
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan. Infusystems Holdings operates under Medical Instruments Supplies classification in the United States and is traded on AMEX Exchange. It employs 4 people. InfuSystems Holdings (INFU) is traded on NYSE MKT Exchange in USA. It is located in 3851 West Hamlin Road, Rochester Hills, MI, United States, 48309 and employs 499 people. InfuSystems Holdings is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

InfuSystems Holdings Leadership Team

Elected by the shareholders, the InfuSystems Holdings' board of directors comprises two types of representatives: InfuSystems Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of InfuSystems. The board's role is to monitor InfuSystems Holdings' management team and ensure that shareholders' interests are well served. InfuSystems Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, InfuSystems Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Ruiz, Ex Officer
Barry CPA, Executive CFO
BSN MBA, COO Pres
Jeanie Latz, Corporate Secretary
Richard Diiorio, President CEO, Director
Jeannine Sheehan, Exec Officer
Jerod Funke, Executive Officer
Barry Steele, Executive CFO
Addam Chupa, Executive Officer

InfuSystems Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is InfuSystems Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for InfuSystems Stock Analysis

When running InfuSystems Holdings' price analysis, check to measure InfuSystems Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InfuSystems Holdings is operating at the current time. Most of InfuSystems Holdings' value examination focuses on studying past and present price action to predict the probability of InfuSystems Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InfuSystems Holdings' price. Additionally, you may evaluate how the addition of InfuSystems Holdings to your portfolios can decrease your overall portfolio volatility.